UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Learn which cash back cards are best this year and make informed decisions for your spending. Start saving today!
27,489 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
March 2026 yielded an all-time high for new business registrations, with 624,915 formations, followed by 560,194 in A...
MacKenzie Scott’s philanthropy dominated megagifts in 2025, representing roughly one-third of the year’s total. New d...
The spring 2026 Trustees Report shows social security’s trillion funding gap has grown to roughly $30 trillion, accel...
Virginia-based City Lending Inc. is winding down operations as regulators tighten oversight and the mortgage market c...
World Liberty Financial unveils a tiered node system tied to WLFI staking, boosting governance influence for long-ter...
Bitcoin climbed toward the $70,000 mark as oil prices slid on indications that Middle East tensions might ease. Trade...
Bitcoin trades around $55K as ETFs diverge in approach. This timely analysis explains what bitcoin $55k means for IBI...
A 1949 recording captures the oldest known humpback song off Bermuda, offering a window into an ocean once times quie...
Seoul lawmakers push to scrap the 22% crypto gains tax slated for 2025, arguing the policy is unfair to everyday inve...
Insider moves can reveal clues about a company's near-term prospects. This article dives into the remitly director's ...
Bitcoin held near $80,000 as oil rose and the dollar strengthened, signaling a possible self-driven pull in BTC beyon...